Victor Tiroille, Adrien Krug, Emma Bokobza, Michel Kahi, Mattijs Bulcaen, Marjolein M Ensinck, Maarten H Geurts, Delilah Hendriks, François Vermeulen, Frédéric Larbret, Alejandra Gutierrez-Guerrero, Yu Chen, Indra Van Zundert, Susana Rocha, Anne C Rios, Louise Medaer, Rik Gijsbers, Philippe E Mangeot, Hans Clevers, Marianne S Carlon, Frédéric Bost, Els Verhoeyen
Genome engineering has become more accessible thanks to the CRISPR-Cas9 gene-editing system. However, using this technology in synthetic organs called "organoids" is still very inefficient. This is due to the delivery methods for the CRISPR-Cas9 machinery, which include electroporation of CRISPR-Cas9 DNA, mRNA, or ribonucleoproteins containing the Cas9-gRNA complex. However, these procedures are quite toxic for the organoids. Here, we describe the use of the "nanoblade (NB)" technology, which outperformed by far gene-editing levels achieved to date for murine- and human tissue-derived organoids...
September 12, 2023: Molecular Therapy. Nucleic Acids